Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Current Liabilities (2021 - 2025)

PAVmed (PAVM) has 5 years of Total Current Liabilities data on record, last reported at $10.5 million in Q3 2025.

  • For Q3 2025, Total Current Liabilities changed N/A year-over-year to $10.5 million; the TTM value through Sep 2025 reached $10.5 million, changed N/A, while the annual FY2024 figure was $35.4 million, 34.57% down from the prior year.
  • Total Current Liabilities reached $10.5 million in Q3 2025 per PAVM's latest filing, roughly flat from $10.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $55.0 million in Q1 2024 and bottomed at $7.6 million in Q4 2021.
  • Average Total Current Liabilities over 5 years is $34.1 million, with a median of $40.0 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: surged 445.12% in 2022, then tumbled 82.22% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $7.6 million in 2021, then soared by 445.12% to $41.2 million in 2022, then surged by 31.5% to $54.2 million in 2023, then tumbled by 34.57% to $35.4 million in 2024, then crashed by 70.49% to $10.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $10.5 million in Q3 2025, $10.5 million in Q2 2025, and $9.8 million in Q1 2025.